Background There is scanty or inconclusive evidence on which cervical cancer screening
tool is effective and suitable for human immunodeficiency virus (HIV)-seropositive women …

Background Sweden revised their cervical cancer screening program in 2017 to include
cytology-based screening for women aged 23–29 years and primary human papillomavirus …

Objective We assessed the cost-effectiveness of mailing a human papillomavirus self-
sampling (HPV-ss) kit, directly or via invitation to order, compared with mailing reminder …

A general concern exists that cervical cancer screening using human papillomavirus (HPV)
testing may lead to considerable overtreatment. We evaluated the trade‐off between …

In Lithuania, cytological screening of cervical cancer (CC) is largely opportunistic. Absence
of standardized systematic invitation practice might be the reason for low participation rates …

Background Lack of consensus in management guidelines for women with minor cervical
lesions, coupled with novel screening approaches, such as human papillomavirus (HPV) …

Objective To evaluate the short‐term consequences and cost‐effectiveness associated with
the use of novel biomarkers to triage young adult women with minor cervical cytological …

Graves et al (1) show that there is no association between guideline adherence-rate
quartiles and ICU or hospital costs in children with severe traumatic brain injury (TBI). Based …

Background: Cervical cancer is a leading cause of cancer related mortality among women
all over the world, with particularly high incidence in developing countries. It is the most …

In Norway, cervical cancer is the third most common cancer among mid-adult women who
are in their productive social and working years. This is despite substantial reductions in …